Public-private partnerships in addressing counterfeit medicines: The development of the Partnership for Safe Medicines and the Partnership for Safe Medicines-India

By LaGanga Scott  

Journal of Commercial Biotechnology, Vol. 17, Iss. 3, 2011-08 ,pp. : 260-265

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Cloning an industry: Strategy typologies of Shanghai biotechnology companies

By Malone Ken   Hales Brent   Chan Justin   Love Monica   Rayner Jeremiah  

Journal of Commercial Biotechnology, Vol. 14, Iss. 1, 2008-01 ,pp. : 31-42

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

The do's and don'ts of partnership

By Hakes L.B.  

Trends in Biotechnology, Vol. 19, Iss. 11, 2001-11 ,pp. : 477-477

Elsevier

Access to resources Recommend Favorite

Needed: models of biotechnology intellectual property

By Gold E.R.   Castle D.   Cloutier L.M.   Daar A.S.   Smith P.J.  

Trends in Biotechnology, Vol. 20, Iss. 8, 2002-08 ,pp. : 327-329

Elsevier

Access to resources Recommend Favorite

The SEC's enforcement programme on biotechnology's communications with the investment community

By Gabinet Arthur S  

Journal of Commercial Biotechnology, Vol. 12, Iss. 3, 2006-04 ,pp. : 182-191

Palgrave Macmillan Ltd

Access to resources Recommend Favorite